ICM
GNTX icon

Invenomic Capital Management’s Gentex GNTX Stock Holding History

Invenomic Capital Management’s Portfolio GNTX Stock Details GNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Sell
88,386
-20,580
-19% -$487K 0.13% 99
2026
Q1 		$2.38M Buy
+108,966
New +$2.53M 0.11% 126
2025
Q2 		– Sell
-244,966
Closed -$5.71M – 170
2025
Q1 		$5.71M Buy
244,966
+118,124
+93% +$3.02M 0.29% 104
2024
Q4 		$3.64M Sell
126,842
-19,932
-14% -$596K 0.17% 125
2024
Q3 		$4.36M Buy
+146,774
New +$4.56M 0.24% 106

Other funds holding GNTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invenomic Capital Management's GNTX Position: Q2 2026 in Review

Invenomic Capital Management reduced its Gentex (GNTX) stake by 19% in Q2 2026, selling an estimated $487K and leaving 88,386 shares worth $2.23M. The position accounts for 0.13% of the portfolio, ranked #99.

Invenomic Capital Management first reported a position in GNTX in Q3 2024 and has held it in 5 quarters since. The position peaked at $5.71M in Q1 2025. 528 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Invenomic Capital Management held 88,386 shares of Gentex worth $2.23M as of Q2 2026.
  • Invenomic Capital Management sold 20,580 Gentex shares in Q2 2026, an estimated $487K.
  • Gentex made up 0.13% of Invenomic Capital Management's portfolio in Q2 2026, its #99 holding.
  • Invenomic Capital Management first reported a position in Gentex in Q3 2024 and has held it in 5 quarters since.
  • Invenomic Capital Management's Gentex position peaked at $5.71M in Q1 2025.
  • 528 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.